Anti-clotting drugs: Not as good as angioplasty?

0 Comments

When it comes to treating coronary artery disease (CAD) and related heart conditions, both anti-clotting medications and angioplasty are vital tools. However, they serve different purposes, and their effectiveness depends on the specific clinical scenario. Understanding the Treatments Anti-Clotting Drugs (Anticoagulants and Antiplatelet Agents) Purpose:These medications prevent the formation of blood clots that can block […]

What Makes TEFCA Different: New Standard Operating Procedure Strengthens Trust

0 Comments

Introduction In the evolving landscape of health information exchange (HIE), establishing trust among stakeholders—patients, providers, health IT developers, and regulators—is paramount. The Trusted Exchange Framework and Common Agreement (TEFCA), initiated by the U.S. Department of Health and Human Services (HHS), aims to create a unified, nationwide framework for health data sharing. A key element in […]

Three Quick Points about the 2024 HHS AI Use Case Inventory

0 Comments

Introduction The Department of Health and Human Services (HHS) has historically played a pivotal role in advancing health innovation, policy, and technology integration. In 2024, the HHS AI Use Case Inventory emerges as a significant strategic initiative aimed at harnessing artificial intelligence (AI) to transform health services, improve outcomes, and ensure ethical, equitable, and effective […]

The Business of Health Care

0 Comments

Introduction Healthcare is a fundamental pillar of society, encompassing the prevention, diagnosis, treatment, and management of illness and disease. Over the decades, the business of healthcare has evolved dramatically from traditional fee-for-service models to complex, multi-layered systems driven by technological innovation, policy changes, and shifting consumer expectations. Understanding the business side of healthcare involves examining […]